Algos
AI-driven algorithmic diagnostics for personalized cancer treatment.
Executive Summary
Algos by Tempus AI is a sophisticated suite of algorithmic diagnostics designed to enhance precision medicine, primarily in oncology. These AI-powered models are integrated with Tempus's comprehensive data platform and assays to provide deeper insights into patient conditions. A key offering within Algos is the Immune Profile Score (IPS), an AI-driven test proven to more accurately predict patient response to immunotherapy compared to traditional biomarkers, thereby guiding more effective treatment strategies. Tempus is actively expanding the Algos portfolio beyond oncology, developing purely algorithmic diagnostics across cardiology, radiology, and pathology. This includes solutions like the PurIST algorithm for identifying molecular subtypes of pancreatic cancer and AI models for transforming tissue analysis in digital pathology. By leveraging extensive real-world data and advanced AI, Algos aims to personalize treatment plans and improve patient outcomes across various disease areas.
Use Cases
- Predicting patient response to immunotherapy using the Immune Profile Score (IPS).
- Identifying molecular subtypes of cancer, such as PurIST for pancreatic cancer.
- Transforming tissue analysis through AI models in digital pathology.
- Developing purely algorithmic diagnostics across oncology, cardiology, radiology, and pathology.
- Personalizing patient treatment plans based on comprehensive data analysis.
Features
Visibility
- Comprehensive Test Access: Provides healthcare providers with comprehensive access to Tempus tests and algorithmic results.
- Patient Profile Overview: Visualizes patient clinical and genomic data to support personalized treatment planning.
Intelligence
- Immunotherapy Prediction (IPS): Utilizes AI to predict patient response to immunotherapy with high accuracy.
- Molecular Subtype Identification: Identifies specific molecular subtypes of cancer (e.g., PurIST for pancreatic cancer) to guide therapy.
- AI-Powered Tissue Analysis: Applies AI models to pathology data for advanced tissue optimization and analysis.
Technical Specifications
- Architecture
- Cloud-based, AI/ML driven platform leveraging large language models and integrated data sources for precision medicine.
- Deployment
- SaaS
- API Available
- Yes
AI/ML Stack
- Machine Learning
- Deep Learning
- Large Language Models (LLMs)
Integrations
- EHR Systems
Pricing
- Model
- Reimbursement-based / Per-test
- Starting Price
- Contact sales
- Target Customer
- Mid-Market,Enterprise
About Tempus AI
Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.